London Metropolitan University

Overview

The MSc in Cancer Immunotherapy at London Metropolitan University provides an in-depth understanding of harnessing the immune system for cancer prevention and treatment. This program offers insights into essential immunology and pharmacology concepts, alongside the latest advancements in targeted immunotherapies.

• Award: MSc
• Subject area: Cancer Immunotherapy / Immuno-oncology
• Delivery: Please confirm with the programme website for specifics.
• Credits / Duration: Please confirm with the programme website for details.
• Language of instruction: English
• Tuition fees: Please refer to the programme website for current information.
• Intake / Start dates: Please check the programme website for updates.

What you'll study

Modules (indicative):

• Advanced Immunology
• Cancer Immunotherapy
• Cancer Pharmacology
• Cancer: Diagnosis and Therapy
• Molecular Oncology
• Scientific Frameworks for Research

How you learn: The curriculum is designed to advance from foundational immunology and cancer mechanisms to practical applications in immunotherapy and research methodologies. Students will enhance their skills in analyzing scientific literature and data, paving the way for independent research projects.

Assessment: Details regarding assessment types are available in the programme handbook or on the programme website, and may include essays, reports, presentations, and research-based evaluations.

Entry requirements

Applicants typically need a Lower Second Class degree or equivalent qualifications in a relevant field. For specific details regarding entry criteria, please consult the university’s official website.

Career prospects

Graduates of the MSc in Cancer Immunotherapy can pursue diverse career paths in academia, research, pharmaceuticals, and healthcare sectors. The program equips students with the expertise necessary for roles in clinical research, drug development, and therapeutic innovation, contributing to ongoing advancements in cancer treatment.